These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10470859)

  • 1. Mannose 6-phosphate/insulin-like growth factor II receptor mediates the growth-inhibitory effects of retinoids.
    Kang JX; Bell J; Beard RL; Chandraratna RA
    Cell Growth Differ; 1999 Aug; 10(8):591-600. PubMed ID: 10470859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular response to latent TGF-beta1 is facilitated by insulin-like growth factor-II/mannose-6-phosphate receptors on MS-9 cells.
    Ghahary A; Tredget EE; Mi L; Yang L
    Exp Cell Res; 1999 Aug; 251(1):111-20. PubMed ID: 10438576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoic acid alters the intracellular trafficking of the mannose-6-phosphate/insulin-like growth factor II receptor and lysosomal enzymes.
    Kang JX; Bell J; Leaf A; Beard RL; Chandraratna RA
    Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13687-91. PubMed ID: 9811861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers.
    Devi GR; De Souza AT; Byrd JC; Jirtle RL; MacDonald RG
    Cancer Res; 1999 Sep; 59(17):4314-9. PubMed ID: 10485478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of the M6P/IGF-II receptor increases cell proliferation and reduces apoptosis in neonatal rat cardiac myocytes.
    Chen Z; Ge Y; Kang JX
    BMC Cell Biol; 2004 Apr; 5():15. PubMed ID: 15115542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of the mannose 6-phosphate/ insulin-like growth factor-II receptor in human breast cancer cell lines of different invasive potential.
    Xie S; Kang JX
    Med Sci Monit; 2002 Aug; 8(8):BR293-300. PubMed ID: 12165733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
    Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
    Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secreted CREG inhibits cell proliferation mediated by mannose 6-phosphate/insulin-like growth factor II receptor in NIH3T3 fibroblasts.
    Han YL; Guo P; Sun MY; Guo L; Luan B; Kang J; Yan CH; Li SH
    Genes Cells; 2008 Sep; 13(9):977-86. PubMed ID: 18691225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of retinoic acid receptor function alters the growth inhibitory response of oral SCC cells to retinoids.
    Le Q; Dawson MI; Soprano DR; Soprano KJ
    Oncogene; 2000 Mar; 19(11):1457-65. PubMed ID: 10723137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble insulin-like growth factor II/mannose 6-phosphate receptor inhibits DNA synthesis in insulin-like growth factor II sensitive cells.
    Scott CD; Weiss J
    J Cell Physiol; 2000 Jan; 182(1):62-8. PubMed ID: 10567917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) variants in American and Japanese populations.
    Killian JK; Oka Y; Jang HS; Fu X; Waterland RA; Sohda T; Sakaguchi S; Jirtle RL
    Hum Mutat; 2001; 18(1):25-31. PubMed ID: 11438990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) in carcinogenesis.
    Martin-Kleiner I; Gall Troselj K
    Cancer Lett; 2010 Mar; 289(1):11-22. PubMed ID: 19646808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M6P/IGF2R is mutated in squamous cell carcinoma of the lung.
    Kong FM; Anscher MS; Washington MK; Killian JK; Jirtle RL
    Oncogene; 2000 Mar; 19(12):1572-8. PubMed ID: 10734317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis induction in cancer cells by a novel analogue of 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid lacking retinoid receptor transcriptional activation activity.
    Dawson MI; Hobbs PD; Peterson VJ; Leid M; Lange CW; Feng KC; Chen Gq ; Gu J; Li H; Kolluri SK; Zhang Xk ; Zhang Y; Fontana JA
    Cancer Res; 2001 Jun; 61(12):4723-30. PubMed ID: 11406543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells.
    Chen Y; Dokmanovic M; Stein WD; Ardecky RJ; Roninson IB
    Cancer Res; 2006 Sep; 66(17):8749-61. PubMed ID: 16951191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imprinted M6p/Igf2 receptor is mutated in rat liver tumors.
    Mills JJ; Falls JG; De Souza AT; Jirtle RL
    Oncogene; 1998 May; 16(21):2797-802. PubMed ID: 9652747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The secreted glycoprotein CREG inhibits cell growth dependent on the mannose-6-phosphate/insulin-like growth factor II receptor.
    Di Bacco A; Gill G
    Oncogene; 2003 Aug; 22(35):5436-45. PubMed ID: 12934103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylation-independent binding to extracellular domains 11-13 of mannose-6-phosphate/insulin-like growth factor-2 receptor mediates the effects of soluble CREG on the phenotypic modulation of vascular smooth muscle cells.
    Han Y; Luan B; Sun M; Guo L; Guo P; Tao J; Deng J; Wu G; Liu S; Yan C; Li S
    J Mol Cell Cardiol; 2011 Apr; 50(4):723-30. PubMed ID: 21195083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of effective retinoids for inhibiting growth and inducing apoptosis in bladder cancer cells.
    Zou C; Liebert M; Zou C; Grossman HB; Lotan R
    J Urol; 2001 Mar; 165(3):986-92. PubMed ID: 11176527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF-II/mannose 6-phosphate receptor activation induces metalloproteinase-9 matrix activity and increases plasminogen activator expression in H9c2 cardiomyoblast cells.
    Chang MH; Kuo WW; Chen RJ; Lu MC; Tsai FJ; Kuo WH; Chen LY; Wu WJ; Huang CY; Chu CH
    J Mol Endocrinol; 2008 Aug; 41(2):65-74. PubMed ID: 18495691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.